High Utilization of Potentially Inappropriate Medications in Alzheimer and Insomnia Populations Leads to Increased Healthcare Burden

Total healthcare costs were 14% higher for patients with potentially inappropriate medication use in the Alzheimer-insomnia cohort, with significant contributions from inpatient care, ambulatory care, and pharmacy costs.:

Source: Neurology Read More

Previous PostBiogen and Stoke Therapeutics Reach Collaborative Agreement for Development of Disease-Modifying Therapy Zorevunersen
Next PostAdvancing Therapeutic Knowledge of Genetic Influence in ALS: Matt Harms, MD

High Utilization of Potentially Inappropriate Medications in Alzheimer and Insomnia Populations Leads to Increased Healthcare Burden

Previous PostBiogen and Stoke Therapeutics Reach Collaborative Agreement for Development of Disease-Modifying Therapy Zorevunersen

Next PostAdvancing Therapeutic Knowledge of Genetic Influence in ALS: Matt Harms, MD

Related Posts

<![CDATA[Telitacicept Moves Forward in Global Phase 3 Study for Generalized Myasthenia Gravis]]>

<![CDATA[Once-Daily Alixorexton Improves Cognition, Fatigue, and Disease Severity in Phase 2 Narcolepsy Type 1 Study]]>

<![CDATA[NMOSD Associated With Escalation to Rituximab, Elecsys NfL Test Receives European Approval, Neurology by the Numbers]]>

Categories